Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 in preschool children with recurrent respiratory tract infections
2016-002705-19Phase 4Completed
- Sponsor
- IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
- Start
- Jan 2018
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of OM-85 in Airways Infection (2 arms), sponsored by IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico. Primary endpoint: Mean cumulative number of acute respiratory tract infections over 6 months. Started Jan 2018; status: completed.
02
Drugs
OM-85
03
Conditions
Airways Infection
Beyond the preview
Go deeper on 2016-002705-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002705-19.